The mortality and morbidity associated with neonatal bacterial meningitis have remained significant despite advances in antimicrobial chemotherapy and supportive care. Inadequate knowledge of the pathogenesis and pathophysiology has contributed to this unacceptably high mortality and morbidity. E. coli is the most common gram-negative organism that causes meningitis during the neonatal period. Most cases of E. coli meningitis in newborns develop as a result of hematogenous spread. We have established an infant rat model of experimental hematogenous meningitis which mimics human E. coli infection (e.g. age dependency, hematogenous infection of meninges without the need for adjuvant or direct inoculation of bacteria into cerebrospinal fluid). We have also established as in vitro model of the blood brain barrier using brain microvascular endothelial cells (BMEC). Using these in vitro and in vivo systems, we so far have shown that successful traversal of E. coli across the blood-brain barrier is a complex process involving multiple steps of E. coli-host interactions, e.g., S fimbriae for binding to BMEC, outer membrane protein A and other proteins for invasion into BMEC, and the K1 capsule for protection from killing. Also, we showed that chito-oligomers (specific for wheat germ agglutinin) were able to block the invasion of E. coli into BMEC both in vitro and in vivo suggesting that GIcNAc-14-GlcNAc specific receptors on BMEC interact with E. coli invasion. In addition, we have successfully developed immortalized BMEC cell lines. Based on the resources and findings derived from the past funding period, we should be able to examine the following specific aims: 1. To further elucidate E. coli structures that contribute to invasion of the blood-brain barrier in vitro and in vivo. 2. To identify and characterize (BMEC proteins that are involved in invasion of E. coli. The information derived from this proposal should enhance our understanding of the pathogenesis and prevention of E. coli meningitis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
3R01NS026310-11S1
Application #
6094774
Study Section
Special Emphasis Panel (ZRG5 (02))
Program Officer
Kerza-Kwiatecki, a P
Project Start
1988-03-01
Project End
2000-11-30
Budget Start
1998-12-01
Budget End
1999-11-30
Support Year
11
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Children's Hospital of Los Angeles
Department
Type
DUNS #
094878337
City
Los Angeles
State
CA
Country
United States
Zip Code
90027
Kim, Kwang Sik (2016) Human Meningitis-Associated Escherichia coli. EcoSal Plus 7:
Tarazi, Carine; Agostoni, Carlo; Kim, Kwang Sik (2014) The placental microbiome and pediatric research. Pediatr Res 76:218-9
Ecker, K L; Donohue, P K; Kim, K S et al. (2013) The impact of group B Streptococcus prophylaxis on early onset neonatal infections. J Neonatal Perinatal Med 6:37-44
Wang, Ming-Hsien; Kim, Kwang Sik (2013) Cytotoxic necrotizing factor 1 contributes to Escherichia coli meningitis. Toxins (Basel) 5:2270-80
Ecker, K L; Donohue, P K; Kim, K S et al. (2013) The impact of group B streptococcus prophylaxis on late-onset neonatal infections. J Perinatol 33:206-11
Maruvada, Ravi; Zhu, Longkun; Pearce, Donna et al. (2012) Cryptococcus neoformans phospholipase B1 activates host cell Rac1 for traversal across the blood-brain barrier. Cell Microbiol 14:1544-53
Yu, Hao; Kim, Kwang Sik (2012) mRNA context dependent regulation of cytotoxic necrotizing factor 1 translation by GidA, a tRNA modification enzyme in Escherichia coli. Gene 491:116-22
Giri, Chandrakant P; Shima, Kensuke; Tall, Ben D et al. (2012) Cronobacter spp. (previously Enterobacter sakazakii) invade and translocate across both cultured human intestinal epithelial cells and human brain microvascular endothelial cells. Microb Pathog 52:140-7
Kim, Kwang S (2012) Current concepts on the pathogenesis of Escherichia coli meningitis: implications for therapy and prevention. Curr Opin Infect Dis 25:273-8
Müller, Marcus; Frese, Achim; Nassenstein, Isabelle et al. (2012) Serum from interferon-?-1b-treated patients with early multiple sclerosis stabilizes the blood-brain barrier in vitro. Mult Scler 18:236-9

Showing the most recent 10 out of 103 publications